Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

What symbol and exchange does Immunome shares trade?

Immunome trades on the NASDAQ stock market under the symbol IMNM.

What is Immunome stock price doing today?

As of November 13, 2026, IMNM stock price climbed to $18.77 with 857,603 million shares trading.

What is Immunome's Beta?

IMNM has a beta of 1.26, meaning it tends to be more sensitive to market movements. IMNM has a correlation of 0.10 to the broad based SPY ETF.

How much is Immunome worth?

IMNM has a market cap of $2.21 billion. This is considered a Mid Cap stock.

How much money does Immunome make?

Last quarter Immunome reported $0 in Revenue and -$.76 earnings per share. This fell short of revenue expectation by $-506,664 and missed earnings estimates by -$.15.

What is the highest and lowest price Immunome traded in the last 3 year period?

In the last 3 years, IMNM traded as high as $30.96 and as low as $5.15.

What are the top ETFs holding Immunome?

The top ETF exchange traded funds that IMNM belongs to (by Net Assets): VTI, IWM, XBI, VXF, IWO.

Is Immunome (IMNM) a good investment?

IMNM has outperformed the market in the last year with a price return of +13.7% while the SPY ETF gained +13.4%. However, in the short term, IMNM had mixed performance relative to the market. It has underperformed in the last 3 months, returning -29.0% vs -2.8% return in SPY. But in the last 2 weeks, IMNM shares have fared better than the market returning +3.1% compared to SPY -0.2%.

What are the support and resistance levels for Immunome (IMNM)?

IMNM support price is $17.90 and resistance is $19.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IMNM shares will trade within this expected range on the day.